NewsBot
05-09-2008, 11:50 AM
Abilify (aripiprazole), a commonly-prescribed antipsychotic medication used to treat bipolar disorder and schizophrenia, received U.S. Food and Drug Administration (FDA) approval yesterday for use within children for Bipolar I Disorder, and teens with schizophrenia. The FDA approval was specifically for maintenance treatment of manic or mixed episodes, and as add-on treatment to lithium [...]
More... (http://psychcentral.com/news/2008/05/09/abilify-receives-approval-for-expanded-use-in-children-teens/2261.html)
More... (http://psychcentral.com/news/2008/05/09/abilify-receives-approval-for-expanded-use-in-children-teens/2261.html)